Ectopic pregnancy – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 10:52:11 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Ectopic pregnancy – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Mifepristone and Letrozole for Treating Ectopic Pregnancy in Comparison to Methotrexate https://clinicaltrials.eu/trial/study-on-mifepristone-and-letrozole-for-treating-ectopic-pregnancy-in-comparison-to-methotrexate/ Wed, 29 Apr 2026 14:23:52 +0000 https://clinicaltrials.eu/trial/study-on-mifepristone-and-letrozole-for-treating-ectopic-pregnancy-in-comparison-to-methotrexate/ This clinical trial is focused on studying the treatment of ectopic pregnancy, a condition where a fertilized egg implants outside the uterus, often in a fallopian tube. The study will compare two treatment options: a combination of the medications mifepristone and letrozole, and the medication methotrexate. Mifepristone, also known by its code name RU-486, is typically used to terminate early pregnancies, while letrozole is often used in breast cancer treatment. Methotrexate is a medication that can treat certain types of cancer and autoimmune diseases, and it is also used to treat ectopic pregnancies.

The purpose of this study is to determine if the combination of mifepristone and letrozole is as effective as methotrexate in treating ectopic pregnancy. Participants in the study will be randomly assigned to receive either the combination of mifepristone and letrozole or methotrexate. The study will monitor the participants over a period to see how well the treatments work in resolving the ectopic pregnancy without the need for additional medical or surgical intervention.

Throughout the study, researchers will also observe any side effects or adverse events related to the treatments. The study aims to provide valuable information on the effectiveness and safety of these treatment options for ectopic pregnancy, potentially offering new insights into managing this condition. Participants will be closely monitored by healthcare professionals to ensure their safety and well-being during the trial.

]]>